ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.

Saved in:
Bibliographic Details
Title: ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
Authors: Gibson CM; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: charlesmichaelgibson@gmail.com., Chi G; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Duffy D; CSL Behring, King of Prussia, Pennsylvania, USA., Bahit MC; INECO Neurociencias Rosario, Rosario, Argentina., White H; Green Lane Cardiovascular Service, Te Whatu Ora Health New Zealand, Te Toka Tumai Auckland and University of Auckland, Auckland, New Zealand., Korjian S; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Alexander JH; Duke Clinical Research Institute, Duke Health, Durham, North Carolina, USA., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA., Anschuetz G; CSL Behring, King of Prussia, Pennsylvania, USA., Girgis IG; CSL Behring, King of Prussia, Pennsylvania, USA., Nicolau JC; Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Lopes RD; Duke Clinical Research Institute, Duke Health, Durham, North Carolina, USA; Brazilian Clinical Research Institute, Sao Paulo, Brazil., Cornel JH; Radboud University Medical Center, Nijmegen and Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands., Bainey KR; Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta, Canada., Libby P; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sacks FM; Harvard T. H. Chan School of Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ridker PM; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts, USA., Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Peter Munk Cardiac Center, University Health Network, University of Toronto, Toronto, Ontario, Canada., Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia., Pocock SJ; London School of Hygiene and Tropical Medicine, London, United Kingdom., Mehran R; Icahn School of Medicine at Mount Sinai, Zena and The Michael A. Wiener Cardiovascular Institute, New York, New York, USA., Harrington RA; Weill Cornell Medicine, New York, New York, USA.
Corporate Authors: AEGIS-II Committees and Investigators
Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Nov 26; Vol. 84 (22), pp. 2185-2192. Date of Electronic Publication: 2024 Sep 02.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-3597
DOI:10.1016/j.jacc.2024.08.001